Yoda Pharmaceuticals Inc. (7829)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
43. 50
+1.85
+4.4418%
NT$
4.59B Market Cap
- P/E Ratio
- Div Yield
42,059 Volume
- Eps
NT$ 41.65
Previous Close Want to track 7829 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Yoda Pharmaceuticals Inc. (7829) Statistics
Valuation metrics
Market Cap 4.59B
Enterprise value 2.96B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 3.51
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.59
Overview
Shares outstanding 99.39M
Float 54.92M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 68.33K
Average volume (90 days) 111.7K
Price summary
52-Week low 36
52-Week high 77.6
Beta -
50-Day moving average 44.73
200-Day moving average 54.03
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.29%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -390.21M
Net income to common (ttm) -407.22M
Diluted EPS (ttm) -5.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 325.38M
Total cash per share (mrq) 4.1
Total debt (mrq) 811K
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 32.42%
Book value per share (mrq) 12.39
Cash Flow
Cash flow statement -353.39M
Levered free cash flow (LFCF) -856.53M
